nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.114	0.18	CbGbCtD
Gemfibrozil—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0946	0.15	CbGbCtD
Gemfibrozil—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0793	0.126	CbGbCtD
Gemfibrozil—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0757	0.12	CbGbCtD
Gemfibrozil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0496	0.0785	CbGbCtD
Gemfibrozil—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0478	0.0757	CbGbCtD
Gemfibrozil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0461	0.073	CbGbCtD
Gemfibrozil—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.037	0.0586	CbGbCtD
Gemfibrozil—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0339	0.0538	CbGbCtD
Gemfibrozil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0212	0.0335	CbGbCtD
Gemfibrozil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0194	0.0307	CbGbCtD
Gemfibrozil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0209	CbGbCtD
Gemfibrozil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000414	0.00112	CcSEcCtD
Gemfibrozil—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000412	0.00112	CcSEcCtD
Gemfibrozil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000409	0.00111	CcSEcCtD
Gemfibrozil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.00111	CcSEcCtD
Gemfibrozil—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00111	CcSEcCtD
Gemfibrozil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000408	0.00111	CcSEcCtD
Gemfibrozil—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000405	0.0011	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000405	0.0011	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000404	0.0011	CcSEcCtD
Gemfibrozil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000404	0.0011	CcSEcCtD
Gemfibrozil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000403	0.00109	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000403	0.00109	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00109	CcSEcCtD
Gemfibrozil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0004	0.00109	CcSEcCtD
Gemfibrozil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0004	0.00109	CcSEcCtD
Gemfibrozil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000397	0.00108	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000396	0.00107	CcSEcCtD
Gemfibrozil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00107	CcSEcCtD
Gemfibrozil—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000394	0.00107	CcSEcCtD
Gemfibrozil—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000393	0.00107	CcSEcCtD
Gemfibrozil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00106	CcSEcCtD
Gemfibrozil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.00106	CcSEcCtD
Gemfibrozil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000391	0.00106	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00106	CcSEcCtD
Gemfibrozil—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000391	0.00106	CcSEcCtD
Gemfibrozil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000388	0.00105	CcSEcCtD
Gemfibrozil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000386	0.00105	CcSEcCtD
Gemfibrozil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000385	0.00104	CcSEcCtD
Gemfibrozil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000385	0.00104	CcSEcCtD
Gemfibrozil—Rash—Topotecan—peripheral nervous system neoplasm	0.000385	0.00104	CcSEcCtD
Gemfibrozil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000384	0.00104	CcSEcCtD
Gemfibrozil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00104	CcSEcCtD
Gemfibrozil—Cough—Etoposide—peripheral nervous system neoplasm	0.000383	0.00104	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000383	0.00104	CcSEcCtD
Gemfibrozil—Headache—Topotecan—peripheral nervous system neoplasm	0.000382	0.00104	CcSEcCtD
Gemfibrozil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000382	0.00104	CcSEcCtD
Gemfibrozil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000382	0.00104	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000382	0.00104	CcSEcCtD
Gemfibrozil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00103	CcSEcCtD
Gemfibrozil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00103	CcSEcCtD
Gemfibrozil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000381	0.00103	CcSEcCtD
Gemfibrozil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00038	0.00103	CcSEcCtD
Gemfibrozil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00038	0.00103	CcSEcCtD
Gemfibrozil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00038	0.00103	CcSEcCtD
Gemfibrozil—Headache—Tretinoin—peripheral nervous system neoplasm	0.000379	0.00103	CcSEcCtD
Gemfibrozil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000379	0.00103	CcSEcCtD
Gemfibrozil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00103	CcSEcCtD
Gemfibrozil—Pain—Vincristine—peripheral nervous system neoplasm	0.000378	0.00103	CcSEcCtD
Gemfibrozil—Constipation—Vincristine—peripheral nervous system neoplasm	0.000378	0.00103	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000377	0.00102	CcSEcCtD
Gemfibrozil—Rash—Melphalan—peripheral nervous system neoplasm	0.000377	0.00102	CcSEcCtD
Gemfibrozil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000376	0.00102	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.00102	CcSEcCtD
Gemfibrozil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000373	0.00101	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000373	0.00101	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000371	0.00101	CcSEcCtD
Gemfibrozil—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000369	0.001	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000991	CcSEcCtD
Gemfibrozil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000364	0.000989	CcSEcCtD
Gemfibrozil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.000984	CcSEcCtD
Gemfibrozil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000362	0.000983	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000361	0.000981	CcSEcCtD
Gemfibrozil—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000361	0.00098	CcSEcCtD
Gemfibrozil—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000977	CcSEcCtD
Gemfibrozil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000359	0.000976	CcSEcCtD
Gemfibrozil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000359	0.000976	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000358	0.000972	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000356	0.000966	CcSEcCtD
Gemfibrozil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000355	0.000963	CcSEcCtD
Gemfibrozil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000355	0.000963	CcSEcCtD
Gemfibrozil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000351	0.000952	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000351	0.000951	CcSEcCtD
Gemfibrozil—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000948	CcSEcCtD
Gemfibrozil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000349	0.000948	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000947	CcSEcCtD
Gemfibrozil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000348	0.000944	CcSEcCtD
Gemfibrozil—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000939	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000936	CcSEcCtD
Gemfibrozil—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000926	CcSEcCtD
Gemfibrozil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.000918	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000917	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000337	0.000916	CcSEcCtD
Gemfibrozil—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000909	CcSEcCtD
Gemfibrozil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000334	0.000907	CcSEcCtD
Gemfibrozil—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000904	CcSEcCtD
Gemfibrozil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.000893	CcSEcCtD
Gemfibrozil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000324	0.000881	CcSEcCtD
Gemfibrozil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000877	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000874	CcSEcCtD
Gemfibrozil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000874	CcSEcCtD
Gemfibrozil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000321	0.000872	CcSEcCtD
Gemfibrozil—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000869	CcSEcCtD
Gemfibrozil—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000866	CcSEcCtD
Gemfibrozil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000318	0.000864	CcSEcCtD
Gemfibrozil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000317	0.00086	CcSEcCtD
Gemfibrozil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.000853	CcSEcCtD
Gemfibrozil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.000852	CcSEcCtD
Gemfibrozil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000312	0.000846	CcSEcCtD
Gemfibrozil—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000842	CcSEcCtD
Gemfibrozil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000839	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000309	0.000839	CcSEcCtD
Gemfibrozil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000309	0.000838	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000837	CcSEcCtD
Gemfibrozil—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000832	CcSEcCtD
Gemfibrozil—Pain—Etoposide—peripheral nervous system neoplasm	0.000306	0.000831	CcSEcCtD
Gemfibrozil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000306	0.000831	CcSEcCtD
Gemfibrozil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000306	0.00083	CcSEcCtD
Gemfibrozil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000303	0.000823	CcSEcCtD
Gemfibrozil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000302	0.000821	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000809	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000808	CcSEcCtD
Gemfibrozil—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000802	CcSEcCtD
Gemfibrozil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000295	0.000801	CcSEcCtD
Gemfibrozil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000294	0.000797	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000293	0.000794	CcSEcCtD
Gemfibrozil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000292	0.000793	CcSEcCtD
Gemfibrozil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.000791	CcSEcCtD
Gemfibrozil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000785	CcSEcCtD
Gemfibrozil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000784	CcSEcCtD
Gemfibrozil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.00078	CcSEcCtD
Gemfibrozil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000777	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000774	CcSEcCtD
Gemfibrozil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000284	0.000772	CcSEcCtD
Gemfibrozil—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.00077	CcSEcCtD
Gemfibrozil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000768	CcSEcCtD
Gemfibrozil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000283	0.000768	CcSEcCtD
Gemfibrozil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000768	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000763	CcSEcCtD
Gemfibrozil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000281	0.000763	CcSEcCtD
Gemfibrozil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00028	0.000761	CcSEcCtD
Gemfibrozil—Rash—Vincristine—peripheral nervous system neoplasm	0.000279	0.000756	CcSEcCtD
Gemfibrozil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000278	0.000756	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000753	CcSEcCtD
Gemfibrozil—Headache—Vincristine—peripheral nervous system neoplasm	0.000277	0.000751	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000747	CcSEcCtD
Gemfibrozil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000272	0.000739	CcSEcCtD
Gemfibrozil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000726	CcSEcCtD
Gemfibrozil—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000716	CcSEcCtD
Gemfibrozil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000263	0.000712	CcSEcCtD
Gemfibrozil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000711	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000706	CcSEcCtD
Gemfibrozil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000257	0.000697	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000697	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000691	CcSEcCtD
Gemfibrozil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000253	0.000687	CcSEcCtD
Gemfibrozil—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000677	CcSEcCtD
Gemfibrozil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000674	CcSEcCtD
Gemfibrozil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000672	CcSEcCtD
Gemfibrozil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000669	CcSEcCtD
Gemfibrozil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000668	CcSEcCtD
Gemfibrozil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000245	0.000665	CcSEcCtD
Gemfibrozil—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000663	CcSEcCtD
Gemfibrozil—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000658	CcSEcCtD
Gemfibrozil—Tension—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000655	CcSEcCtD
Gemfibrozil—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000653	CcSEcCtD
Gemfibrozil—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000648	CcSEcCtD
Gemfibrozil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000237	0.000642	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000639	CcSEcCtD
Gemfibrozil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000232	0.00063	CcSEcCtD
Gemfibrozil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000629	CcSEcCtD
Gemfibrozil—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000627	CcSEcCtD
Gemfibrozil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000621	CcSEcCtD
Gemfibrozil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000228	0.000618	CcSEcCtD
Gemfibrozil—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000617	CcSEcCtD
Gemfibrozil—Rash—Etoposide—peripheral nervous system neoplasm	0.000226	0.000613	CcSEcCtD
Gemfibrozil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000226	0.000612	CcSEcCtD
Gemfibrozil—Headache—Etoposide—peripheral nervous system neoplasm	0.000224	0.000609	CcSEcCtD
Gemfibrozil—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000608	CcSEcCtD
Gemfibrozil—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000606	CcSEcCtD
Gemfibrozil—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000605	CcSEcCtD
Gemfibrozil—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.0006	CcSEcCtD
Gemfibrozil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000221	0.0006	CcSEcCtD
Gemfibrozil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000598	CcSEcCtD
Gemfibrozil—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000597	CcSEcCtD
Gemfibrozil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000586	CcSEcCtD
Gemfibrozil—Cough—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000582	CcSEcCtD
Gemfibrozil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000582	CcSEcCtD
Gemfibrozil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000578	CcSEcCtD
Gemfibrozil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000213	0.000577	CcSEcCtD
Gemfibrozil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000571	CcSEcCtD
Gemfibrozil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000568	CcSEcCtD
Gemfibrozil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000568	CcSEcCtD
Gemfibrozil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000568	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000564	CcSEcCtD
Gemfibrozil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000555	CcSEcCtD
Gemfibrozil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000554	CcSEcCtD
Gemfibrozil—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000553	CcSEcCtD
Gemfibrozil—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000549	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000545	CcSEcCtD
Gemfibrozil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000545	CcSEcCtD
Gemfibrozil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000543	CcSEcCtD
Gemfibrozil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000539	CcSEcCtD
Gemfibrozil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000536	CcSEcCtD
Gemfibrozil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000535	CcSEcCtD
Gemfibrozil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000534	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000533	CcSEcCtD
Gemfibrozil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000529	CcSEcCtD
Gemfibrozil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000526	CcSEcCtD
Gemfibrozil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000526	CcSEcCtD
Gemfibrozil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000526	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000522	CcSEcCtD
Gemfibrozil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000508	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000504	CcSEcCtD
Gemfibrozil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000504	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000496	CcSEcCtD
Gemfibrozil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000496	CcSEcCtD
Gemfibrozil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000494	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000493	CcSEcCtD
Gemfibrozil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000489	CcSEcCtD
Gemfibrozil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000489	CcSEcCtD
Gemfibrozil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000484	CcSEcCtD
Gemfibrozil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000479	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00047	CcSEcCtD
Gemfibrozil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00047	CcSEcCtD
Gemfibrozil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000466	CcSEcCtD
Gemfibrozil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000466	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000459	CcSEcCtD
Gemfibrozil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000452	CcSEcCtD
Gemfibrozil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000449	CcSEcCtD
Gemfibrozil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000448	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000445	CcSEcCtD
Gemfibrozil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000444	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000435	CcSEcCtD
Gemfibrozil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000434	CcSEcCtD
Gemfibrozil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000433	CcSEcCtD
Gemfibrozil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000431	CcSEcCtD
Gemfibrozil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000431	CcSEcCtD
Gemfibrozil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000431	CcSEcCtD
Gemfibrozil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000415	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000412	CcSEcCtD
Gemfibrozil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.0004	CcSEcCtD
Gemfibrozil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000398	CcSEcCtD
Gemfibrozil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000391	CcSEcCtD
Gemfibrozil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000385	CcSEcCtD
Gemfibrozil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000373	CcSEcCtD
Gemfibrozil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000362	CcSEcCtD
Gemfibrozil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00036	CcSEcCtD
Gemfibrozil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000357	CcSEcCtD
Gemfibrozil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000346	CcSEcCtD
Gemfibrozil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000345	CcSEcCtD
Gemfibrozil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000343	CcSEcCtD
Gemfibrozil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000343	CcSEcCtD
Gemfibrozil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000341	CcSEcCtD
Gemfibrozil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000333	CcSEcCtD
Gemfibrozil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000323	CcSEcCtD
Gemfibrozil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00032	CcSEcCtD
Gemfibrozil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000318	CcSEcCtD
Gemfibrozil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000317	CcSEcCtD
Gemfibrozil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000316	CcSEcCtD
Gemfibrozil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000299	CcSEcCtD
